Tracy Robson

Royal College of Surgeons in Ireland — Ireland

Biochemistry, Genetics and Molecular Biology · Life Sciences

47h-index6.0kcitations228works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Signaling Pathways in Disease(43), RNA Interference and Gene Delivery(35), Cancer, Hypoxia, and Metabolism(25), Virus-based gene therapy research(21), Peptidase Inhibition and Analysis(18)

Publications228 total

Peptidyl-prolyl cis/trans isomerases in GtoPdb v.2025.3
IUPHAR/BPS Guide to Pharmacology CITE·2025Open Access
Exercise Impacts on Maternal Cardiovascular Dysfunction and Rescues Fetal Growth Restriction in a Nanoparticle-Induced Mouse Model of Angiogenic Imbalance in Preeclampsia
Heart Lung and Circulation·2025Open Access
Improving Resident Doctors’ Consideration of Spirituality/Religious Beliefs in Clinical Assessments
BJPsych Open·2025Open Access
Resident Doctors’ Perspectives and Experiences with Spiritual/Religious Considerations: A Survey-Based Project
BJPsych Open·2025Open Access
Translating Basic Science Discoveries into Clinical Advances: Highlights from the EACR-AACR-IACR 2024 Conference in Celebration of Irish Association for Cancer Research’s 60th Anniversary
Cancers·2025Open Access
FK506 binding protein like, FKBPL, as a novel therapeutic target in 2D and 3D bioprinted, models of cardiac fibrosis
Bioprinting·2025· 1 citedOpen Access
Emerging Role of FK506-Binding-Protein-Like (FKBPL) in a New 3D Bioprinted Model of Cardiac Fibrosis
Heart Lung and Circulation·2024Open Access
Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference
Cancers·2024· 5 citedOpen Access
Glycolytic reprogramming fuels myeloid cell-driven hypercoagulability
Journal of Thrombosis and Haemostasis·2023· 10 citedOpen Access
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes
British Journal of Pharmacology·2023· 423 citedOpen Access
Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
Frontiers in Endocrinology·2023· 55 citedOpen Access
Peptidyl-prolyl cis/trans isomerases in GtoPdb v.2023.1
IUPHAR/BPS Guide to Pharmacology CITE·2023Open Access
Glycolytic reprogramming fuels myeloid cell-driven hypercoagulability
2023· 1 citedOpen Access
Figure S1 from Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway
2023Open Access
Figure S4 from Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway
2023Open Access
Figure S4 from Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway
2023Open Access
Supplementary Data from Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-ribose) Polymerase: a Contributory Factor to Chemopotentiation <i>In vivo</i>?
2023Open Access
Figure S2 from Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway
2023Open Access
Supplementary Data from FKBPL and Peptide Derivatives: Novel Biological Agents That Inhibit Angiogenesis by a CD44-Dependent Mechanism
2023Open Access
Figure S7 from Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Helen O. McCarthy(22), David G. Hirst(12), Stephanie Annett(11), Cian M. McCrudden(11), Lana McClements(9), Anita Yakkundi(9), Ahlam Ali(7), Hayley D. McKeen(7), Jenny Worthington(7), Joanne McCaffrey(6), J.W. McBride(6), Nicholas Dunne(6), Martin O’Rourke(6), Grace Cole(5), Ryan F. Donnelly(5), Victoria Kett(4), Gillian Moore(4), Jonathan A. Coulter(4), Adrien Kissenpfennig(4), Amy Short(4)